These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16284369)

  • 1. Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.
    Ramsey SD; Burke W; Pinsky L; Clarke L; Newcomb P; Khoury MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2494-500. PubMed ID: 16284369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
    Ramsey SD; Wilschut J; Boer R; van Ballegooijen M
    Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
    Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis.
    Thomas C; Mandrik O; Saunders CL; Thompson D; Whyte S; Griffin S; Usher-Smith JA
    Cancer Prev Res (Phila); 2021 Aug; 14(8):811-822. PubMed ID: 34039685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.
    Palimaka S; Blackhouse G; Goeree R
    Ont Health Technol Assess Ser; 2015; 15(15):1-43. PubMed ID: 26366240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
    Ladabaum U; Ferrandez A; Lanas A
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
    Ladabaum U; Mannalithara A; Mitani A; Desai M
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
    Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
    Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
    Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
    Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
    van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG
    Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
    van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
    Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer.
    Menges M; Gärtner B; Georg T; Fischinger J; Zeitz M
    Int J Colorectal Dis; 2006 Sep; 21(6):596-601. PubMed ID: 16284773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.
    Naber SK; Kuntz KM; Henrikson NB; Williams MS; Calonge N; Goddard KAB; Zallen DT; Ganiats TG; Webber EM; Janssens ACJW; van Ballegooijen M; Zauber AG; Lansdorp-Vogelaar I
    Gastroenterology; 2018 Jan; 154(1):105-116.e20. PubMed ID: 28964749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
    Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG
    J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer.
    Kuntz KM; Popp J; Beck JR; Zauber AG; Weinberg DS
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32933928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.